Novartis Profit Climbs on Demand for Cancer Pill, Hypertension Treatment
32491
Novartis AG, Switzerland s biggest drugmaker, said third-quarter profit rose 21 percent as demand increased for the hypertension treatment Diovan and the cancer pill Gleevec.
760003
Medtronic Inc.  reported higher  quarterly profit on Tuesday as demand for its spine, vascular  and neurology products offset weak sales of its implantable  devices to shock racing hearts back to normal rhythm.
596613
Sanofi-Aventis SA, the world&#39;s third- largest drugmaker, said predecessor company Sanofi-Synthelabo SA&#39;s first-half profit rose 21 percent, helped by demand for the blood thinner Plavix and the cancer treatment Eloxatin.
531579
Medco Health Solutions Inc. , one of the largest U.S. managers of drug benefits, said on Wednesday fourth-quarter profit rose, helped by higher rates of dispensing generic medicines.
235034
BASEL, Switzerland  - Net profit at Roche Holding AG  rose 34 percent to 9.17 billion Swiss francs ($7.33 billion) in 2006 due to strong sales of cancer treatments Herceptin and Avastin, just ahead of analysts' expectations.
743669
UnitedHealth Group Inc. , the second biggest managed health care company, on Thursday said profit rose as its premiums outpaced the soaring cost of medical care.
690923
Walgreen Co. (WAG.N: Quote, Profile, Research) , the top US drugstore chain, on Monday said quarterly profit rose 18.1 percent due to rising prescription demand and strong sales from its
684039
BASEL, Switzerland  - Net profits at Novartis AG  rose by a lower-than-expected 15 percent last year as  restructuring costs weighed, the company reported on Thursday,  but the world's sixth biggest drugmaker said it expects record  sales and profits in 2005.
217992
Johnson &amp; Johnson  on Tuesday  said its second-quarter profit rose on higher sales of its  medical devices and prescription medicines.
154759
Boston Scientific Corp. BSX.N on  Tuesday said its quarterly net earnings rose as sales of its  new cardiovascular device bolstered results despite a costly  recall.
641779
Schering-Plough Corp.  on  Monday reported quarterly earnings far higher than Wall Street  expected, fueled by growing demand for its drugs against  cholesterol, arthritis, allergies and hepatitis C.
139031
Boston Scientific Corp. (BSX.N: Quote, Profile, Research) on Tuesday said its quarterly net earnings rose as sales of its new cardiovascular device bolstered results despite a costly recall.
135025
Walgreen Co., the top US drugstore chain, said Monday its quarterly profit rose 18.1 percent due to rising prescription demand and strong sales from its highly profitable nonpharmacy segment, including digital photo processing.
573112
Eli Lilly and Co.  on Thursday said its third-quarter earnings rose as growing demand for its medicines offset higher spending to market recently approved treatments.
308820
Abbott Laboratories Inc.  on Tuesday said its fourth-quarter profit rose 3.2 percent on higher sales of its prescription drugs, including its popular new treatment for rheumatoid arthritis, Humira.
681000
Novartis  missed  expectations with a 4 percent rise in second-quarter net income  to &#36;1.713 billion on Monday, as heavy charges from the Swiss  drug giant&#039;s acquisition of U.S. biotech firm Chiron weighed.
365281
Genentech Inc.  said on  Tuesday second-quarter profit rose 79 percent on demand for  cancer medicines and raised its full-year forecast, but its  stock fell as sales of colon cancer drug Avastin disappointed.